TR200102265T2 - Anesthetic regulation. - Google Patents

Anesthetic regulation.

Info

Publication number
TR200102265T2
TR200102265T2 TR2001/02265T TR200102265T TR200102265T2 TR 200102265 T2 TR200102265 T2 TR 200102265T2 TR 2001/02265 T TR2001/02265 T TR 2001/02265T TR 200102265 T TR200102265 T TR 200102265T TR 200102265 T2 TR200102265 T2 TR 200102265T2
Authority
TR
Turkey
Prior art keywords
anesthetic
regulation
delta
medicament
derivatives
Prior art date
Application number
TR2001/02265T
Other languages
Turkish (tr)
Inventor
John Douglas Pomfrett Christopher
Alkire Michael
Haier Richard
Fallon Jim
Original Assignee
The Victoria University Of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9902469.7A external-priority patent/GB9902469D0/en
Application filed by The Victoria University Of Manchester filed Critical The Victoria University Of Manchester
Publication of TR200102265T2 publication Critical patent/TR200102265T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu bulus, anestezi düenlemesi için bir ilacin imalati için Delta Uykusu Saglayan Peptid'in veya bunun biyolojik bakimdan aktif fragman ve türevlerinin kullanimi ile ilgilidir.This invention relates to the use of Delta Sleeping Sleep Peptide or its biologically active fragments and derivatives for the manufacture of a medicament for anesthetic regulation.

TR2001/02265T 1999-02-05 2000-02-01 Anesthetic regulation. TR200102265T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9902469.7A GB9902469D0 (en) 1999-02-05 1999-02-05 Brain metabolism
US12032699P 1999-02-17 1999-02-17
US15566199P 1999-09-24 1999-09-24

Publications (1)

Publication Number Publication Date
TR200102265T2 true TR200102265T2 (en) 2001-12-21

Family

ID=27269636

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02265T TR200102265T2 (en) 1999-02-05 2000-02-01 Anesthetic regulation.

Country Status (15)

Country Link
EP (1) EP1148887A2 (en)
JP (1) JP2002536337A (en)
KR (1) KR20010101992A (en)
CN (1) CN1346278A (en)
AP (1) AP2001002245A0 (en)
AU (1) AU2445900A (en)
BR (1) BR0008046A (en)
CA (1) CA2360124A1 (en)
ID (1) ID30518A (en)
IL (1) IL144572A0 (en)
MX (1) MXPA01007949A (en)
NO (1) NO20013795L (en)
OA (1) OA11758A (en)
TR (1) TR200102265T2 (en)
WO (1) WO2000045832A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275308A1 (en) * 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
KR20100056524A (en) * 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
CN108376559B (en) * 2018-02-28 2020-10-16 复旦大学附属中山医院 Application of acetaldehyde dehydrogenase 2 genotype in calculation of anesthetic dose
CN112535727A (en) * 2020-12-24 2021-03-23 安域生物制药(杭州)有限公司 Short peptide gel with sleep improvement effect and preparation method thereof
CN112908454B (en) * 2021-02-26 2023-08-29 西安交通大学口腔医院 Method and system for intelligently keeping anesthetic

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634331A5 (en) * 1977-06-30 1983-01-31 Hoffmann La Roche PHOSPHORYLATED NONAPEPTIDES AND METHOD FOR THE PRODUCTION THEREOF.
CA1188989A (en) * 1981-05-21 1985-06-18 Richard R. Scherschlicht Nonapeptide for the treatment of drug withdrawal symptoms
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE
RU2104717C1 (en) * 1995-07-07 1998-02-20 Новокузнецкий государственный институт усовершенствования врачей Method of applying anesthesia when operating on patients with leriche's syndrome

Also Published As

Publication number Publication date
WO2000045832A2 (en) 2000-08-10
KR20010101992A (en) 2001-11-15
NO20013795D0 (en) 2001-08-02
ID30518A (en) 2001-12-13
CN1346278A (en) 2002-04-24
OA11758A (en) 2005-07-19
BR0008046A (en) 2001-11-06
EP1148887A2 (en) 2001-10-31
CA2360124A1 (en) 2000-08-10
AP2001002245A0 (en) 2001-09-30
AU2445900A (en) 2000-08-25
WO2000045832A3 (en) 2000-11-30
MXPA01007949A (en) 2003-06-04
NO20013795L (en) 2001-08-02
IL144572A0 (en) 2002-05-23
JP2002536337A (en) 2002-10-29

Similar Documents

Publication Publication Date Title
GB0123381D0 (en) Factor
DE69917609D1 (en) MEDICINAL PRODUCTS AND THE USE THEREOF
NO20015584L (en) Long-lasting insulin-tropic peptides and conjugates and use in the manufacture of medicaments for treatment
NZ512866A (en) A nutritional composition comprising at least one tolerogenic peptide, selected for its ability to induce oral tolerance, as an active ingredient
ATE206308T1 (en) MEDICINAL COMPOSITIONS CONTAINING A BACTERICIDAL PERMEABILITY-INCREASE PROTEIN AND A SURFACTANT
DE60121988D1 (en) COMBINATION THERAPY WITH ANTIDIBLE AND ANTICONVULSIVE AGENTS
DE60225118D1 (en) COMBINED USE OF FACTOR VII POLYPEPTIDES AND FACTOR VIII POLYPEPTIDES
UY26082A1 (en) DERIVATIVES OF 1,4-DIAZABICICLO [3.2.2] NONAN-4-CARBOXILATO AND -CARBOXAMIDAS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
ATE290015T1 (en) CYCLOSPORINE DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS
DE69400435D1 (en) USE OF CARBAMAZEPINE AND OXCARBAZEPINE FOR THE TREATMENT OF PARKINSON AND THE PARKINSON SYNDROME
BR0014378A (en) Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
TR200103819T2 (en) ET743 compositions and uses in cancer treatment
BR0008228A (en) Compositions of n-benzoyl staurosporine spontaneously dispersible
HK1068606A1 (en) Novel aminobenzoephenones
TR200101633T2 (en) Pharmaceutical composition
BR0013353A (en) Combination of active substance with clonidine
ATE216256T1 (en) PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING ERYTHROPOIETIN AND IRON PREPARATIONS
BG106155A (en) Novel derivatives and analogues of galanthamin
GB0016189D0 (en) Cosmetic composition
ATE281155T1 (en) DRUG ADMINISTRATION OF PROTEINS FROM POLYMER MIXTURES
TR199903197T2 (en) Use of a specific 5HT2 receptor antagonist for the preparation of drugs useful in the treatment of sleep apnea syndrome.
TR200102265T2 (en) Anesthetic regulation.
BR0014740A (en) Lantibiotic
TR200103151T2 (en) A pharmaceutical formulation containing a carboxypeptidase U inhibitor and a thrombin inhibitor.
ATE504309T1 (en) USE OF OXYTOCIN FOR PREPARING A PHARMACEUTICAL COMPOSITION AGAINST CARCINOMA IN SITU AND CERVICITIS